How should an infiltrated intravenous dextrose infusion be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Infiltrated IV Dextrose

Stop the infusion immediately, leave the cannula in place, attempt gentle aspiration of extravasated fluid through the existing line, then remove the cannula and apply ice for at least 10 minutes while elevating the limb 1, 2, 3.

Immediate Actions (First 10 Minutes)

When you suspect dextrose infiltration based on swelling, pain, or resistance to infusion:

  1. Stop the infusion immediately - Do not flush or apply manual pressure over the infiltrated area 1

  2. Leave the cannula in place initially - With the cannula still inserted, attempt to gently aspirate as much extravasated solution as possible through the existing IV line. Document the volume removed 1

  3. Remove the cannula - After aspiration attempt, carefully remove the IV catheter

  4. Apply ice immediately - Place ice packs on the affected area for a minimum of 10 minutes. This decreases pain, reduces infiltration size, and may decrease tissue damage 2, 3. Continue ice application for 20 minutes at a time, 3-4 times daily for 1-2 days 1

  5. Elevate the extremity - Keep the affected limb elevated above heart level 1

  6. Assess the extent of injury - Measure and document the area of swelling, assess distal circulation, and check for signs of compartment syndrome 2

Pharmacologic Intervention: Hyaluronidase

Consider hyaluronidase injection for moderate to large dextrose infiltrations, particularly with hypertonic dextrose solutions 4, 5. The evidence specifically supports this intervention for dextrose extravasation:

  • Dosing: Inject 0.2 mL of hyaluronidase (150 U/mL) using a 25-gauge needle at 5 different sites along the leading edge of the erythematous area 4
  • Mechanism: Hyaluronidase degrades hyaluronic acid, improving absorption and dispersion of the extravasated dextrose 1, 4
  • Timing: Most effective when administered early, ideally within the first few hours 4, 5
  • Evidence: Case reports demonstrate successful resolution of dextrose extravasation injuries without long-term sequelae when hyaluronidase is used promptly 4, 5

What NOT to Do

  • Do not apply heat - Cold therapy is indicated for dextrose infiltration 1
  • Do not apply manual pressure over the extravasated area, as this may worsen tissue damage 1
  • Do not use corticosteroids - Subcutaneous or intralesional corticoids are not recommended and may worsen outcomes 1
  • Do not use DMSO - This is only indicated for specific chemotherapy extravasations (anthracyclines, mitomycin C, platinum salts), not for dextrose 1

Monitoring and Follow-Up

  • Refrain from using the affected extremity for dialysis access for at least one treatment if applicable 3
  • Monitor closely for compartment syndrome - Assess for progressive swelling, severe pain, paresthesias, pallor, or pulselessness
  • Document thoroughly - Record the estimated volume infiltrated, interventions performed, and serial assessments 1, 6
  • Follow-up assessment at 48 hours and again at 1-2 weeks to ensure resolution 4, 5
  • Surgical consultation if tissue necrosis develops, pain persists beyond 10 days, or compartment syndrome is suspected 1, 6

Prevention for Future Access

The FDA label specifically warns that concentrated dextrose solutions are hypertonic and may cause phlebitis and thrombosis 7. To prevent future infiltrations:

  • Use large veins in the forearm for peripheral administration 1
  • Administer slowly through a small-bore needle into a large vein to minimize venous irritation 7
  • Consider central venous access for concentrated dextrose solutions or prolonged infusions 7
  • Ensure proper catheter securement and avoid cannulation over joints 1
  • Monitor continuously during infusion for early signs of infiltration 1

Critical Pitfall

The most important pitfall is delayed recognition and treatment. Dextrose, particularly in hypertonic concentrations (≥10%), can cause significant tissue damage if extravasation is not promptly addressed. While most infiltrations have minor sequelae, delayed treatment can result in tissue necrosis requiring surgical debridement, skin grafting, or even amputation 4, 6. The combination of immediate ice application, limb elevation, and early hyaluronidase administration offers the best outcomes for preventing serious complications 4, 5.

References

Guideline

kdoqi clinical practice guideline for vascular access: 2019 update.

American Journal of Kidney Diseases, 2020

Guideline

clinical practice guidelines for vascular access.

American Journal of Kidney Diseases, 2006

Research

Hyaluronidase for the management of dextrose extravasation.

The American journal of emergency medicine, 2010

Research

Infiltration and extravasation: update on prevention and management.

Journal of infusion nursing : the official publication of the Infusion Nurses Society, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.